Terms: = Leukemia AND STAT5B, STAT5, 6777, ENSG00000173757, P51692 AND Diagnosis
40 results:
1. Ponatinib and stat5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid leukemia Cells.
Tezcanli Kaymaz B; Gumus N; Celik B; Alcitepe İ; Biray Avci C; Aktan C
J Interferon Cytokine Res; 2024 Apr; 44(4):178-189. PubMed ID: 38579140
[TBL] [Abstract] [Full Text] [Related]
2. DNMTs-mediated SOCS3 methylation promotes the occurrence and development of AML.
Zhang X; Zhang K; Zhang J; Chang W; Zhao Y; Suo X
Eur J Haematol; 2024 Mar; 112(3):439-449. PubMed ID: 37950514
[TBL] [Abstract] [Full Text] [Related]
3. Immune profiling after allogeneic hematopoietic cell transplantation in pediatric acute myeloid leukemia.
Shahid S; Ceglia N; Le Luduec JB; McPherson A; Spitzer B; Kontopoulos T; Bojilova V; Panjwani MK; Roshal M; Shah SP; Abdel-Wahab O; Greenbaum B; Hsu KC
Blood Adv; 2023 Sep; 7(17):5069-5081. PubMed ID: 37327118
[TBL] [Abstract] [Full Text] [Related]
4. JAK2/stat5 Pathway Mutation Frequencies in South African BCR/ABL Negative MPN Patients.
Shires KL; Rust AJ; Harryparsad R; Coburn JA; Gopie RE
Hematol Oncol Stem Cell Ther; 2023 Apr; 16(3):291-302. PubMed ID: 37023224
[TBL] [Abstract] [Full Text] [Related]
5. T-Cell Prolymphocytic leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 Cases.
Hu Z; Medeiros LJ; Xu M; Yuan J; Peker D; Shao L; Tang Z; Mai B; Thakral B; Rios A; Hu S; Wang W
Am J Clin Pathol; 2023 Apr; 159(4):325-336. PubMed ID: 36883805
[TBL] [Abstract] [Full Text] [Related]
6. Not all LGL leukemias are created equal.
Semenzato G; Calabretto G; Barilà G; Gasparini VR; Teramo A; Zambello R
Blood Rev; 2023 Jul; 60():101058. PubMed ID: 36870881
[TBL] [Abstract] [Full Text] [Related]
7. [A particular presentation of a T cell large granular lymphocytic leukaemia].
Donzel M; Bon Mardion M; Balme B
Ann Pathol; 2023 Jan; 43(1):52-56. PubMed ID: 36494259
[TBL] [Abstract] [Full Text] [Related]
8. All that glitters is not LGL leukemia.
Semenzato G; Teramo A; Calabretto G; Gasparini VR; Zambello R
Leukemia; 2022 Nov; 36(11):2551-2557. PubMed ID: 36109593
[TBL] [Abstract] [Full Text] [Related]
9. Characterization of Philadelphia-like Pre-B Acute Lymphoblastic leukemia: Experiences in Mexican Pediatric Patients.
Martínez-Anaya D; Moreno-Lorenzana D; Reyes-León A; Juárez-Figueroa U; Dean M; Aguilar-Hernández MM; Rivera-Sánchez N; García-Islas J; Vieyra-Fuentes V; Zapata-Tarrés M; Juárez-Villegas L; Paredes-Aguilera R; Vega-Vega L; Rivera-Luna R; Juárez-Velázquez MDR; Pérez-Vera P
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076986
[TBL] [Abstract] [Full Text] [Related]
10. CRLF2 and IKZF1 abnormalities in Mexican children with acute lymphoblastic leukemia and recurrent gene fusions: exploring surrogate markers of signaling pathways.
Moreno Lorenzana D; Juárez Velázquez MDR; Reyes León A; Martínez Anaya D; Hernández Monterde A; Salas Labadía C; Navarrete Meneses MDP; Zapata Tarrés M; Juárez Villegas L; Jarquín Ramírez B; Cárdenas Cardós R; Herrera Almanza M; Paredes Aguilera R; Pérez Vera P
J Pathol Clin Res; 2021 Jul; 7(4):410-421. PubMed ID: 33890726
[TBL] [Abstract] [Full Text] [Related]
11. T-cell large granular lymphocytic (LGL) leukemia consists of CD4
Kuwahara N; Kodaka T; Zushi Y; Sasaki M; Goka T; Maruoka H; Aoyama Y; Tsunemine H; Yamane T; Kobayashi J; Kawakami T; Ishida F; Itoh T; Takahashi T
J Clin Exp Hematop; 2019; 59(4):202-206. PubMed ID: 31866622
[TBL] [Abstract] [Full Text] [Related]
12. Characterization of a rarely reported stat5b/RARA gene fusion in a young adult with newly diagnosed acute promyelocytic leukemia with resistance to ATRA therapy.
Peterson JF; He RR; Nayer H; Cuevo RS; Smadbeck JB; Vasmatzis G; Greipp PT; Ketterling RP; Hoppman NL; Baughn LB
Cancer Genet; 2019 Sep; 237():51-54. PubMed ID: 31447065
[TBL] [Abstract] [Full Text] [Related]
13. Recurrent activating stat5b N642H mutation in myeloid neoplasms with eosinophilia.
Cross NCP; Hoade Y; Tapper WJ; Carreno-Tarragona G; Fanelli T; Jawhar M; Naumann N; Pieniak I; Lübke J; Ali S; Bhuller K; Burgstaller S; Cargo C; Cavenagh J; Duncombe AS; Das-Gupta E; Evans P; Forsyth P; George P; Grimley C; Jack F; Munro L; Mehra V; Patel K; Rismani A; Sciuccati G; Thomas-Dewing R; Thornton P; Virchis A; Watt S; Wallis L; Whiteway A; Zegocki K; Bain BJ; Reiter A; Chase A
Leukemia; 2019 Feb; 33(2):415-425. PubMed ID: 30573779
[TBL] [Abstract] [Full Text] [Related]
14. Latest Advances in the diagnosis and Treatment of Large Granular Lymphocytic leukemia.
Moignet A; Lamy T
Am Soc Clin Oncol Educ Book; 2018 May; 38():616-625. PubMed ID: 30231346
[TBL] [Abstract] [Full Text] [Related]
15. Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia.
De Bie J; Demeyer S; Alberti-Servera L; Geerdens E; Segers H; Broux M; De Keersmaecker K; Michaux L; Vandenberghe P; Voet T; Boeckx N; Uyttebroeck A; Cools J
Leukemia; 2018 Jun; 32(6):1358-1369. PubMed ID: 29740158
[TBL] [Abstract] [Full Text] [Related]
16. Hepatosplenic T-cell Lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors.
Yabe M; Miranda RN; Medeiros LJ
Hum Pathol; 2018 Apr; 74():5-16. PubMed ID: 29337025
[TBL] [Abstract] [Full Text] [Related]
17. Somatic
Savola P; Brück O; Olson T; Kelkka T; Kauppi MJ; Kovanen PE; Kytölä S; Sokka-Isler T; Loughran TP; Leirisalo-Repo M; Mustjoki S
Haematologica; 2018 Feb; 103(2):304-312. PubMed ID: 29217783
[TBL] [Abstract] [Full Text] [Related]
18. Imatinib mesylate inhibits stat5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients.
Thiant S; Moutuou MM; Laflamme P; Sidi Boumedine R; Leboeuf DM; Busque L; Roy J; Guimond M
Blood Cancer J; 2017 Apr; 7(4):e551. PubMed ID: 28387753
[TBL] [Abstract] [Full Text] [Related]
19. [FLT3 Mutations in Acute Myeloid leukemia].
Shoji T; Kida Y; Yamashita K; Ichiyama S
Rinsho Byori; 2017 Jan; 65(1):44-51. PubMed ID: 30695511
[TBL] [Abstract] [Full Text] [Related]
20. Clinicopathologic Characterization of Aggressive Natural Killer Cell leukemia Involving Different Tissue Sites.
Gao LM; Zhao S; Liu WP; Zhang WY; Li GD; Küçük C; Hu XZ; Chan WC; Tang Y; Ding WS; Yan JQ; Yao WQ; Wang JC
Am J Surg Pathol; 2016 Jun; 40(6):836-46. PubMed ID: 26975038
[TBL] [Abstract] [Full Text] [Related]
[Next]
